The US government's arrest of a Libyan asylee who helped advance precision medicine casts a dark shadow on rare disease research, which requires access to a global population, experts say.

Federal immigration enforcement action may be winding down, but healthcare professionals say the "collective trauma" ICE inflicted on the community will be long lasting.

Distance, lack of coverage, and mistrust have limited Indigenous patients' access to basic and advanced medicine, but cancer centers are embracing strategies to change that.

Heads up voters, the deadline to register to vote or change an address is Oct. 6 for the upcoming municipal elections. Cities across the state will elect their leaders. One statewide race for the Publ...

Some oncologists and researchers have raised concerns about delays in the completion of confirmatory trials, but FDA now has new tools to push them ahead.

The lab, one of three branches of the NCHHSTP's Division of Viral Hepatitis, was eliminated while working on several ongoing hepatitis outbreaks.

Researchers warn NIH divestment from research could hinder progress at a pivotal moment for advances in precision cancer medicine.

Researchers have been "making great inroads" in precision medicine, and a 15 percent cap on indirect costs could quash the momentum, experts worry.

News and reporting on ASH from Precision Medicine Online Precision Oncology

As the popularity of drugs like Ozempic and Mounjaro soar, researchers, doctors, biotechs, and diagnostic firms see a role for biomarkers to guide their use.

Alt: a dog sitting on a couch with the words hello there written below it